Journal of Antimicrobial Chemotherapy, Vol 39, 223-228, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy
I Herrera-Insua, P Perez, P Martinez, ML Gomez-Lus and J Prieto
The analysis of the interaction between antimicrobials and phagocytosis in
vitro provides information additional to standard MIC and MBC estimations
in predicting in-vivo efficacy. This study investigated the effects of
meropenem, a newly available carbapenem, on the activities of human
neutrophils against Escherichia coli and Staphylococcus aureus. The results
were compared with those obtained with imipenem. Pretreatment of E. coli
and S. aureus with meropenem and imipenem sensitized the bacteria to
leucocytic killing. In the presence of antibiotics, opsonophagocytic
killing of E. coli, but not S. aureus, was synergistically enhanced.
JOURNAL ARTICLE
Meropenem-induced alteration of the susceptibility of Escherichia coli and Staphylococcus aureus to the bactericidal activity of human polymorphonuclear leucocytes
Departamento de Microbiologia, Facultad de Medicina, Universidad Complutense de Madrid, Spain.
![]()
CiteULike
Connotea
Del.icio.us What's this?